Geopolitics
Swiss Biotech vs US-Chinese Geopolitics: Which Supply Chain Wins?
Swiss biotech’s neutral stance shields firms from major trade shocks, delivering a measurable ROI advantage. In 2024, more than 40% of critical bio-pharmaceutical ingredients sourced in Switzerland avoided U.S.-China tariff fallout, thanks to autonomous regulatory frameworks. Executives who embed geopolitical risk analysis into their decision-making see lower